Kalaris Therapeutics, Inc. ( KLRS ) is a clinical-stage biopharmaceutical company focused on developing treatments for prevalent retinal diseases. The company's lead drug candidate, TH103 , is a next-generation anti-VEGF therapy being studied in neovascular age-related macular degeneration (nAMD) and other sight-threatening eye conditions.

IRD is the Nasdaq ticker for Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on gene therapies for inherited retinal diseases (IRDs). The company was formed in October 2024 through the all-stock acquisition of private gene-therapy developer Opus Genetics by Ocuphire Pharma.

Corbus Pharmaceuticals Holdings (CRBP) is a clinical-stage biopharmaceutical company developing new therapies for oncology and obesity. The company is headquartered in Norwood, Massachusetts, and was incorporated in 2009; its Chief Executive Officer is Dr. Yuval Cohen.

Gogoro Inc. (GGR) is a Taiwan-based technology company best known for its electric scooters and its battery-swapping network, the Gogoro Network. The company operates a two-part business model: selling electric two-wheelers and related hardware, plus generating recurring revenue from battery-swapping subscriptions.

FLYX is the stock ticker for flyExclusive, Inc., a vertically integrated private aviation company listed on the NYSE American exchange. The company operates one of the largest private jet fleets in the United States, serving customers through fractional ownership, Jet Club memberships, and on-demand charter.

Pipeline pivot is the central story: After epetraborole's Phase 3 trial in treatment-refractory MAC lung disease missed its primary endpoint, investor focus has shifted to new indications and to the company's boron-chemistry platform rather than the original antibiotic program. Chagas disease program is a key upcoming catalyst: Positive Phase 1 and non-human primate data for AN2-502998 (AN15368) support a planned Phase 2 proof-of-concept study, developed in partnership with the Drugs for Neglected Diseases initiative (DNDi).

Major upcoming catalysts: The next earnings report (estimated around November 16, 2026), the ramp of the Asset Management Agreement (AMA) with New APR Energy, and new edge data center deployments are the most immediate value drivers. Strategic positioning: DUOT is pivoting from a rail-focused machine vision vendor into a diversified intelligent infrastructure company spanning AI rail inspection, edge computing, and behind-the-meter power services.

Idaho Strategic Resources, Inc. (IDR) is a U.S.-based mining company that produces gold while also exploring for silver, base metals, and rare earth elements (REEs) in northern Idaho. The company was formerly known as New Jersey Mining Company and adopted its current name in December 2021; it was incorporated in 1996 and is headquartered in Coeur d'Alene, Idaho.

Duos Technologies Group, Inc. (NASDAQ: DUOT) is a Jacksonville, Florida-based technology company that has repositioned itself as a provider of edge data centers and AI infrastructure. The company operates through subsidiaries focused on modular edge data centers, technology sourcing and integration, and energy consulting and asset management.

CURI is the stock ticker for CuriosityStream Inc., a factual-entertainment streaming and media company founded in 2015 by Discovery Channel founder John S. Hendricks. The company specializes in documentary and non-fiction programming across science, nature, history, technology, society, and lifestyle.

United States Antimony Corporation ( UAMY ) is a U.S.-based mining and processing company focused on antimony, zeolite, and precious metals. The company operates two reportable segments — antimony and zeolite — with facilities in Montana, Mexico, and Idaho.

SBXE is the Class A ordinary share listing of SilverBox Corp V , a blank check company (a type of SPAC, or special purpose acquisition company) incorporated in the Cayman Islands. The company was formed in 2025 to identify and merge with one or more private businesses, bringing them to the public market through a business combination.

Bitcoin price and network difficulty remain the dominant swing factors for BitFuFu's profitability and revenue trajectory, shaping both self-mining economics and demand for cloud-mining contracts. Cloud-mining and hashrate expansion represent the core growth engine, with the company's partnership with mining hardware leader Bitmain supporting its capacity and equipment strategy.

Defense-driven revenue ramp: A five-year, roughly $248 million contract with the U.S. Defense Logistics Agency (DLA, the Pentagon's supply agency) anchors near-term growth, with management guiding to $75–95 million of federal antimony shipments in 2026. Capacity expansion is the core catalyst: The Thompson Falls, Montana smelter expansion is designed to more than triple output, supporting a ramp from roughly 300 metric tonnes per month (MTPM) in 2025 toward 400–500 MTPM in 2026 and potentially higher over the following 12–18 months.

A dual-track transformation is the central story. Following its February 2026 rebrand from Tharimmune, Canton Strategic Holdings now pursues two distinct value streams: a digital asset treasury built around Canton Coin and the Canton Network, alongside legacy clinical-stage biotechnology programs. Institutional blockchain adoption is the defining growth catalyst. The company's positioning as a "Super Validator" and provider of locking-as-a-service gives it direct exposure to the digitization of financial markets, a theme whose pace will depend heavily on regulatory clarity.

Vista Gold Corp. ( VGZ ) is a development-stage gold company whose sole flagship asset is the Mt Todd gold project in Australia's Northern Territory. The company is incorporated in British Columbia, Canada, with its principal executive offices in Englewood, Colorado, and trades on the NYSE American and the Toronto Stock Exchange.

The single most consequential variable for Dingdong's (DDL) stock forecast is the pending sale of its mainland China fresh-grocery business to Meituan, an up to $717 million transaction that could unlock roughly $997 million in total cash proceeds for the listed parent. Antitrust clearance by China's State Administration for Market Regulation (SAMR) is the pivotal catalyst; the agreement carries a long-stop date of February 2027 and a $75 million termination fee if Meituan walks away.

Acquisition catalyst: The September 2026 agreement for Artemis Gold Inc. to acquire Vista Gold via a court-approved plan of arrangement is the dominant near-term driver, subject to shareholder, court, and regulatory approvals. Mt Todd development path: Management is targeting the start of detailed engineering and design by early 2027, initiating an approximately 27-month design, construction, and commissioning phase toward first gold production.

CNTN is the Nasdaq listing for Canton Strategic Holdings, Inc. , a micro-cap company formerly known as Tharimmune, Inc. The company operates two distinct segments: a digital asset treasury strategy centered on the Canton Network and Canton Coin, and a clinical-stage biotechnology research and development arm.

Permitting is the critical path: Mayfair plans to begin the Environmental Assessment (EA) and Ontario permitting process, with a construction decision targeted within two to three years and initial production aimed for 2030. Strong project economics underpin the thesis: The January 2026 Pre-Feasibility Study (PFS) shows an after-tax Net Present Value (NPV) of US$652 million and a 24% Internal Rate of Return (IRR) at a US$3,100/oz base-case gold price.